Clinical Trials Browser

Not yet recruiting × INDUSTRY × Uterine Cervical Neoplasms × Clear all

Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT07497074 2026-03-27

JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer

Phase 2 Not yet recruiting

78 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT07446049 2026-03-03

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

Phase 2 Not yet recruiting

180 enrolled

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT07230626 2025-11-17

SYS6002 vs Chemotherapy in Recurrent or Metastatic Cervical Cancer

Phase 3 Not yet recruiting

412 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT07177716 2025-09-17

Efficacy and Safety of LB1410 Plus Lenvatinib With or Without LB4330 in Advanced Recurrent/Metastatic Cervical Cancer

Phase 2/3 Not yet recruiting

120 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06724263 2024-12-09

A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors

Phase 2 Not yet recruiting

120 enrolled

BreastGastrointestinalGynecologicThoracic

Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Colorectal Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT06672653 2024-11-04

PREPAP

Phase 1/2 Not yet recruiting

66 enrolled

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06519110 2024-07-25

CVL009-C2001

Phase 2 Not yet recruiting

60 enrolled

GastrointestinalGynecologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Salivary Gland Neoplasms, Cholangiocarcinoma

NCT06283875 2024-07-18

The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer

Not yet recruiting

80 enrolled

Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms

NCT06505551 2024-07-17

Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma

Phase 1/2 Not yet recruiting

66 enrolled

GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT06358053 2024-04-10

CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers

Phase 1 Not yet recruiting

24 enrolled

GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms

NCT05789628 2023-03-29

Discovering Factors in Cervical Cancer Patients' Clinical Trial Experiences

Not yet recruiting

500 enrolled

Gynecologic

Uterine Cervical Neoplasms

Clinical Trials

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

SYS6002 vs Chemotherapy in Recurrent or Metastatic Cervical Cancer

Efficacy and Safety of LB1410 Plus Lenvatinib With or Without LB4330 in Advanced Recurrent/Metastatic Cervical Cancer

A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors

PREPAP

CVL009-C2001

The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer

Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma

CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers

Discovering Factors in Cervical Cancer Patients' Clinical Trial Experiences